Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07832825

Effect of Body Mass Index on ICSI Outcomes

This retrospective cohort study aims to evaluate the effect of body mass index on the outcomes of intracytoplasmic sperm injection (ICSI) cycles at Assiut Women Health Hospital.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Infertility Body Weight Female Urogenital Diseases and Pregnancy Complications Genital Diseases Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Pregnancy Complications Signs and Symptoms Urogenital Diseases

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

About this study

Obesity is associated with alterations in reproductive function and may affect the success of assisted reproductive techniques. This observational study will review medical records of women who underwent ICSI cycles.

Patients will be classified according to the World Health Organization body mass index categories: underweight (<18.5 kg/m²), normal weight (18.5-24.99 kg/m²), overweight (25-29.99 kg/m²), and obese (≥30 kg/m²). Pregnancy outcomes will be compared across BMI groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women who underwent ICSI cycles at Assiut Women Health Hospital
  • Recorded weight and height at the start of treatment

Exclusion criteria

  • Cases with no recorded weight or height at registration

Treatment and study plan

Primary outcomes

  1. Clinical Pregnancy Rate After ICSI

    Time frame: At 6 weeks after embryo transfer

    Proportion of women achieving clinical pregnancy defined as positive serum beta-hCG and presence of gestational sac on ultrasound among total ICSI cycles stratified by BMI groups

Secondary outcomes

  1. Ongoing Pregnancy Rate

    Time frame: At 12 weeks after embryo transfer

    Proportion of pregnancies continuing beyond 12 weeks gestation among women who achieved clinical pregnancy stratified by BMI groups

  2. Clinical Abortion Rate

    Time frame: Up to 20 weeks after embryo transfer

    Proportion of clinical pregnancies that result in pregnancy loss before 20 weeks gestation among BMI groups

  3. Live Birth Rate

    Time frame: At 40 weeks after embryo transfer

    Proportion of ICSI cycles resulting in live birth among BMI groups

Study contacts

Contact information is provided by the study sponsor or research team.

Hager M Mohamed, Resident

CONTACT

[email protected]

01554546780

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Effect of Body Mass Index on Intracytoplasmic Sperm Injection Cycles

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Sep 22, 2026
Registry last updated
Sep 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.